Influence of Prior Endoscopic Sinus Surgery Extent on Dupilumab Effectiveness in CRSwNP Patients

Background Guidelines recommend that the vast majority of patients with severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP) should have at least one endoscopic sinus surgery (ESS) prior to starting biologics. Because ESS can be performed with a variable extension, the aim of this s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Laryngoscope 2024-04, Vol.134 (4), p.1556-1563
Hauptverfasser:	Alicandri‐Ciufelli, Matteo, Marchioni, Daniele, Pipolo, Carlotta, Garzaro, Massimiliano, Nitro, Letizia, Dell'Era, Valeria, Ferrella, Francesco, Campagnoli, Massimo, Russo, Paolo, Galloni, Costanza, Ghidini, Angelo, De Corso, Eugenio, Lucidi, Daniela
Format:	Artikel
Sprache:	eng
Schlagworte:	ACCESS score Antibodies, Monoclonal, Humanized biologic therapy Chronic Disease CRSwNP Dupilumab Endoscopy Humans Monoclonal antibodies nasal polyps Nasal Polyps - complications Nasal Polyps - drug therapy Nasal Polyps - surgery Otolaryngology Quality of Life Retrospective Studies Rhinitis - complications Rhinitis - drug therapy Rhinitis - surgery Sinusitis - complications Sinusitis - drug therapy Sinusitis - surgery Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!